2010 Compounding Pharmaceutical Companies 
pharmaphorum
MARCH 19, 2021
The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this. Follow him on Twitter or connect with him on LinkedIn.
European Pharmaceutical Review
MARCH 11, 2024
In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. Ahmed et al.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
APRIL 8, 2024
A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.
Pharmaceutical Technology
MAY 15, 2023
According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry. The structure of quinoline is represented by the fusion of benzene ring with pyridine at two neighbouring carbon atoms.
Pharmaceutical Technology
MARCH 14, 2023
These compounds cause their therapeutic effect by inhibiting DNA synthesis. GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.
pharmaphorum
JUNE 23, 2021
Physician access issues coupled with message delivery disconnects only compounded the problem. Florent Edouard is the global head of commercial excellence at Grünenthal Group , a pharmaceutical company headquartered in Germany and specialized in pain. When the access was actually made, the interaction was not so good.
Pharmaceutical Technology
OCTOBER 25, 2022
Pharmaceutical companies – and the FDA – are embracing FDCs. Between 2010 and the end of 2015, of the 655 New Drug Applications (NDAs) approved by the FDA, 63 were for FDCs. The potential to extend the patent life and market exclusivity of a company’s APIs is a potent financial incentive. The numbers tell the story.
Expert insights. Personalized for you.
141 
Let's personalize your content